Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.90
-
0.000%

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.40
-
33.784%

Risky Investment
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.40
-
33.784%

Risky Investment
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€7.40
-
34.460%

Could be very worthwhile Investment >20% year
Genmark Diagnostics

Start price
Target price
Perf. (%)
€11.20
€12.00
9.821%

Could be worthwhile Investment >10% per year
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€6.70
€8.00
5.970%

Could be worthwhile Investment >10% per year
Cutera Inc.

Start price
Target price
Perf. (%)
€16.40
€18.00
0.000%

Could be worthwhile Investment >10% per year
CHF Solutions Inc

Start price
Target price
Perf. (%)
€0.21
€0.000
-

Could be very worthwhile Investment >20% year
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€4.94
-
49.798%

Risky Investment
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€9.90
-
-

Risky Investment
PerkinElmer Inc.

Start price
Target price
Perf. (%)
€104.00
-
-2.885%

Growths faster than the competition
Could be worthwhile Investment >10% per year
EBIT growth >5% per year expected
Stratec SE

Start price
Target price
Perf. (%)
€103.60
€120.00
-3.089%

Risky Investment
Stratec SE

Start price
Target price
Perf. (%)
€105.60
€95.00
2.652%

Probably not worthwhile Investment
Revenue decline/stagnation expected
High valuation
Very low/no dividend yield expected
Cardiff Oncology Inc.

Start price
Target price
Perf. (%)
€6.65
-
-11.278%

Risky Investment
Motus GI Holdings Inc

Start price
Target price
Perf. (%)
€0.84
-
0.599%

Could be very worthwhile Investment >20% year
CHF Solutions Inc

Start price
Target price
Perf. (%)
€0.21
€2.00
-

Could be very worthwhile Investment >20% year
Idexx Laboratories Inc.

Start price
Target price
Perf. (%)
€321.10
-
-3.083%

EBIT growth >5% per year expected
Very low/no dividend yield expected
Teladoc Health Inc

Start price
Target price
Perf. (%)
€164.88
€200.00
8.491%

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Medtronic plc

Start price
Target price
Perf. (%)
€85.25
-
2.358%

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Normal challenges to pay loans and raise capital
ROE higher than 15% per year
M1 Kliniken AG

Start price
Target price
Perf. (%)
€9.44
€12.00
-4.449%

Could be worthwhile Investment >10% per year
Capable Management
Small cyclical dependencies
Gerresheimer AG

Start price
Target price
Perf. (%)
€90.75
€100.00
4.353%

Baxter International

Start price
Target price
Perf. (%)
€77.61
€85.00
-13.452%

SINTX Technologies Inc.

Start price
Target price
Perf. (%)
€2.14
-
-43.925%

UnitedHealth Group Inc.

Start price
Target price
Perf. (%)
€264.80
€290.00
-5.186%

Anthem Inc.

Start price
Target price
Perf. (%)
€248.65
€275.00
-14.640%